Female Sexual Dysfunction Treatment Market Size is Estimated to grow at a CAGR of 11.3% during the forecast period
The therapy market for female sexual dysfunction treatment market was
estimated to be worth USD 435.2 million globally in 2022, and a compound annual
growth rate (CAGR) of 11.3% is anticipated throughout the projected period. A
female who suffers from sexual dysfunction is unable to enjoy physical closeness
due to a mental health condition.
The market is expanding as a result of chronic diseases
becoming more common. The future growth of the market is significantly impacted
by this element. Because of technology improvements, the sector is expected to
grow at a high rate over the forecast period. The market is expanding
considerably due to the rise in individuals suffering from diabetes and
cardiovascular disease.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/female-sexual-dysfunction-treatment-market
Growth Drivers
The market is growing due to rising patient numbers with
chronic diseases, advances in medical technology, and growing awareness of
sexual health issues. The industry is growing at a substantial rate thanks to
initiatives to de-stigmatize getting treatment. The true reason for the
increase in market revenue is the development of healthcare services and
infrastructure. The industry is expanding as a result of increasing awareness
campaigns and educational initiatives.
Innovation and market expansion are driven by the
increasing investments made by pharmaceutical companies, research institutes,
and healthcare organizations in the study of female sexual health and the
development of innovative treatment modalities. Increasing access to healthcare
services and making it easier to diagnose and treat female sexual dysfunction
are two benefits of expanding the healthcare infrastructure, particularly in
developing nations. The industry is expanding as a result of an increase in the
prevalence of gynecological disorders. The market is expanding due to the rise
in menopausal women's demand for treatment of these illnesses.
The market is expanding as a result of patients
experiencing stress and anxiety at higher rates. A greater emphasis on
telemedicine and remote healthcare has made therapy more accessible for certain
people. Hospitals' resurgence of female patients during the epidemic is driving
market development.
Segmentation
By Route of
Administration
· Oral
· Parenteral
· Topical
By Distribution
Channel
· Hospital
Pharmacies
· Drug
Pharmacies
· Retail
Pharmacies
· Online
Stores
Based on Disease
· Hypoactive
sexual desire disorder
· Dyspareunia
· Others
By Drug Analysis
· Flibanserin
· Bremelanotide
· Ospemifane
· Estrogen
Therapy
· Others
Regional Outlook
· Asia
Pacific
· North
America
· Latin
America
· Europe
· Middle
East and Africa
Key Players
· Pfizer
Inc
· Amag
Pharmaceuticals
· BioSante
Pharmaceuticals
· Shionogi
and Co.
· Patatin
Technologies and Inc
· Teva
Pharmaceuticals Industries Ltd.
· Apricus
Biosciences Inc
· Novartis
· Johnson
and Johnson
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/female-sexual-dysfunction-treatment-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment